Overview

Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Post-marketing surveillance (PMS) to investigate the safety and efficacy of long-term daily use of Mirapex®-LA Tablets in patients with Parkinson's disease.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Pramipexole